ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,626Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1942

$547K Total Retail Price of All Prescriptions

Rank: 61 out of 1942

563 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 563 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 563 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,418 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 645 559 1 1
OMEPRAZOLE 523 461 2 4
LISINOPRIL 494 448 3 2
METOPROLOL SUCCINATE 453 387 4 13
FUROSEMIDE 413 348 5 5
LEVOTHYROXINE SODIUM 374 324 6 3
HYDROCHLOROTHIAZIDE 347 321 7 8
ATENOLOL 304 286 8 7
JANTOVEN 277 270 9 33
HYDROCODONE-ACETAMINOPHEN 231 183 S3 10 12
POLYETHYLENE GLYCOL 3350 226 181 11 28
POTASSIUM CHLORIDE 219 171 12 17
TRAMADOL HCL 218 168 13 19
METOPROLOL TARTRATE 186 158 14 9
METFORMIN HCL ER 171 136 15 46
CITALOPRAM HBR 163 133 16 15
ISOSORBIDE MONONITRATE ER 162 139 17 42
ALLOPURINOL 158 137 18 26
PREDNISONE 157 149 19 27
GABAPENTIN 153 115 20 16
AMLODIPINE BESYLATE 149 141 21 6
METFORMIN HCL 132 94 22 10
LOSARTAN POTASSIUM 130 118 23 18
LANTUS SOLOSTAR 129 97 24 54
PROAIR HFA 121 94 25 41
TAMSULOSIN HCL 112 102 26 29
WARFARIN SODIUM 106 70 27 11
CARBIDOPA-LEVODOPA 102 102 28 64
RANITIDINE HCL 99 93 29 31
KETOCONAZOLE 97 82 30 231
FENTANYL 96 88 S2 31 47
CARVEDILOL 95 73 32 39
SERTRALINE HCL 95 86 32 20
AMITRIPTYLINE HCL 93 66 R 34 65
FLUOXETINE HCL 92 48 35 45
DILTIAZEM ER 86 72 36 121
GLIMEPIRIDE 86 60 36 53
TRIAMTERENE-HCTZ 85 85 38 36
CLOPIDOGREL 83 83 39 55
ZOLPIDEM TARTRATE 81 81 40 25
PAROXETINE HCL 76 38 41 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 66 42 22
LOVASTATIN 73 68 42 32
AZITHROMYCIN 70 58 44 43
GLIPIZIDE XL 68 47 45 109
BACLOFEN 67 16 46 117
DIOVAN HCT 67 67 46 114
FLUTICASONE PROPIONATE 66 49 48 37
NABUMETONE 65 45 49 132
DIGOXIN 63 54 50 40
NAPROXEN 60 54 51 95
PEN NEEDLE 59 51 52 129
NAMENDA 59 59 52 51
AMLODIPINE BESYLATE-BENAZEPRIL 58 50 54 106
TORSEMIDE 56 53 55 124
SPIRIVA 52 52 56 57
ATENOLOL-CHLORTHALIDONE 51 46 57 115
LANTUS 51 46 57 49
TRIAMCINOLONE ACETONIDE 51 47 57 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.